Chinese Pharmaceutical Market

Regular Price: USD 4,950.00

Special Price USD 4,207.50

15% OFF

* Required Fields

Regular Price: USD 4,950.00

Special Price USD 4,207.50


Be the first to review this product

The Chinese pharmaceutical market is expected to be the third-largest in the world in 2013. This research service analyzes various aspects of the Chinese pharmaceutical market between 2007 and 2016. Rising income, improving healthcare infrastructure, and insurance systems are some factors that drive this market. The study discusses in detail the market challenges and opportunities, competitive analysis, offers a revenue forecast, and a list of local company profiles along with their revenue.

Table of Contents

Executive SummaryExecutive SummaryExecutive Summary—Market Engineering MeasurementsExecutive Summary—CEO’s PerspectiveMarket Market Overview—SegmentationMarket Overview—Key Questions This Study Will AnswerGlobal Top 10 Pharmaceutical MarketsMarket Engineering MeasurementsChinese Pharmaceutical Market—Revenue ForecastRevenue Forecast DiscussionMarket Overview of Chinese Pharmaceutical Market—Financial StatusMarket Challenges and OpportunitiesMarket Challenges and Opportunities—Key Challenges for Chinese Pharmaceutical ManufacturersMarket Challenges and Opportunities—Internal Challenges for Pharmaceutical Manufacturers DiscussionIndustry Challenges and Opportunities—External Challenges for Pharmaceutical Manufacturers DiscussionMarket Challenges and Opportunities—Growth Opportunities for Pharmaceutical ManufacturersDistribution Trends and AnalysisDistribution Trends and Analysis—Pharmaceutical Distribution Integration ForecastDistribution Trends and Analysis—Pharmaceutical Distribution Integration Forecast DiscussionDistribution Trends and Analysis—Pharmaceutical Supply Forecast DiscussionCompetitive Competitive Analysis Competitive Analysis (continued) Competitive Analysis (continued) List of Chinese Pharmaceutical Company Names by RevenueTop Chinese Pharmaceutical Industry ParticipantsTop Chinese Pharmaceutical Industry Participants (continued)Company ProfilesCompany Profile—Guangzhou Pharmaceutical Holdings Ltd.Company Profile—Xiuzheng Pharmaceutical Group Co., Ltd. Company Profile—Yangtze River Pharmaceutical GroupCompany Profile—Harbin Pharmaceutical Group Holding Co., Ltd.Company Profile—Shanghai Pharmaceutical Holding Co., Ltd.Company Profile—China Shijiazhuang Pharmaceutical Group Co., Ltd.Company Profile—North China Pharmaceutical Group CorporationCompany Profile—China National Pharmaceutical Group CorporationCompany Profile—China National Pharmaceutical Group Corporation (continued)Company Profile—Northeast Pharmaceutical Group Co. Ltd.Company Profile—China Resources Double-crane Pharmaceutical Co., Ltd.Company Profile—Hangzhou East China Pharmaceutical Group Co., Ltd.Company Profile—Kelun Pharmaceutical Co., Ltd.Company Profile—Heilongjiang Zhenbao Island Pharmaceutical Co., Ltd.Company Profile—Kangmei Pharmaceutical Co., Ltd.Company Profile—Qilu Pharmaceutical Co., Ltd.Company Profile—Furen Medicine Group Ltd.Company Profile—Shanghai Fosun Pharmaceutical (Group) Ltd.Company Profile—China Resources Three Nine Pharmaceutical Co., Ltd.Company Profile—Reyoung Pharmaceutical Co., Ltd.Company Profile—Jiangxi Jimin Kexin Pharmaceutical Co., LtdCompany Profile—Jiangsu Heng Rui Medicine Co., Ltd.Company Profile—Yunnan Baiyao Group Co., Ltd.Company Profile—Luye Pharma Group Ltd.Company Profile—Tianjin Zhongxin Pharmaceutical Group Co., Ltd.Company Profile—Jiangsu Hansoh Pharmaceutical Co., Ltd.Company Profile—Heze Ruiying Pharmaceutical Group Co., Ltd.Company Profile—Zhuhai United Laboratories Pharmaceutical Co., Ltd.Company Profile—Zhejiang NHU Group Holdings Ltd.Company Profile—Taiji Group Holdings Ltd.Company Profile—Lunan Pharmaceutical Group Co., Ltd.Company Profile—Shandong Luoxin Pharmacy Stock Co., Ltd.Company Profile—Shandong Luoxin Pharmacy Stock Co., Ltd. (continued)Company Profile—Jiangsu Chia-tai Tianqing Pharmaceutical Co., Ltd.Company Profile—Renhe (Group) Development Co., Ltd.Company Profile—Zhejiang Medicine Co., Ltd.Company Profile—Wuhan Humanwell Healthcare(Group) Co., Ltd.Company Profile—Nanjing Pharmaceutical Industry (Group) Co., Ltd.Conclusions and RecommendationsConclusions and Recommendations—Game Changing StrategiesConclusions and Recommendations—ConclusionsConclusions and Recommendations—RecommendationsLegal DisclaimerAppendixTable of Acronyms UsedExchange Rate in the StudyThe Frost & Sullivan StoryWho is Frost & SullivanWhat Makes Us Unique TEAM MethodologyOur Global Footprint 40+ Offices

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.